Cargando…

Diagnosis-to-surgery interval and survival for different histologies of stage I–IIA lung cancer

BACKGROUND: Guidelines on timeliness of lung cancer surgery are inconsistent. Lung cancer histologic subtypes have different prognosis and treatment. It is important to understand the consequences of delayed surgery for each lung cancer histologic subtype. This study aimed to examine the association...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lu, Hsieh, Mei-Chin, Rennert, Lior, Neroda, Paige, Wu, Xiao-Cheng, Hicks, Chindo, Wu, Jiande, Gimbel, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350104/ https://www.ncbi.nlm.nih.gov/pubmed/34430346 http://dx.doi.org/10.21037/tlcr-21-168

Ejemplares similares

Racial Disparity and Social Determinants in Receiving Timely Surgery Among Stage I–IIIA Non-small Cell Lung Cancer Patients in a U.S. Southern State
por: Neroda, Paige, et al.
Publicado: (2021)

Breast Cancer Type Classification Using Machine Learning
por: Wu, Jiande, et al.
Publicado: (2021)

CpG Site-Based Signature Predicts Survival of Colorectal Cancer
por: Wu, Jiande, et al.
Publicado: (2022)

Integrating germline and somatic variation information using genomic data for the discovery of biomarkers in prostate cancer
por: Mamidi, Tarun Karthik Kumar, et al.
Publicado: (2019)

Interactions between Germline and Somatic Mutated Genes in Aggressive Prostate Cancer
por: Mamidi, Tarun Karthik Kumar, et al.
Publicado: (2019)

Mapping the Germline and Somatic Mutation Interaction Landscape in Indolent and Aggressive Prostate Cancers
por: Mamidi, Tarun Karthik Kumar, et al.
Publicado: (2019)

Elucidation of the Genomic-Epigenomic Interaction Landscape of Aggressive Prostate Cancer
por: Kumar Mamidi, Tarun Karthik, et al.
Publicado: (2021)

Landscape of Molecular Crosstalk Perturbation between Lung Cancer and COVID-19
por: Kuchi, Aditi, et al.
Publicado: (2022)

Integrating Genomic Information with Tumor-Immune Microenvironment in Triple-Negative Breast Cancer
por: Otohinoyi, David, et al.
Publicado: (2022)

Integrating Germline and Somatic Mutation Information for the Discovery of Biomarkers in Triple-Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2019)

Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2020)

Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2020)

Deconvolution of the Genomic and Epigenomic Interaction Landscape of Triple-Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2019)

Impact of different therapies on the survival of patients with stage I–IIA cervical cancer with intermediate risk factors
por: Nie, Jichan, et al.
Publicado: (2021)

Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance
por: Takahashi, Yusuke, et al.
Publicado: (2018)

Whole Genome Transcriptome Analysis of the Association between Obesity and Triple-Negative Breast Cancer in Caucasian Women
por: Mamidi, Tarun K. K., et al.
Publicado: (2018)

HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells
por: Lyu, Hui, et al.
Publicado: (2023)

Improved Survival after Breast-Conserving Therapy Compared with Mastectomy in Stage I-IIA Breast Cancer
por: Ratosa, Ivica, et al.
Publicado: (2021)

Microscopical Variables and Tumor Inflammatory Microenvironment Do Not Modify Survival or Recurrence in Stage I-IIA Lung Adenocarcinomas
por: Dell’Amore, Andrea, et al.
Publicado: (2023)

Survival Contradiction Between Stage IIA and Stage IIIA Rectal Cancer: A Retrospective Study
por: Mo, Shaobo, et al.
Publicado: (2018)

Monocytosis as a prognostic factor for survival in stage IB and IIA cervical cancer
por: Eo, Wan Kyu, et al.
Publicado: (2018)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
por: Lee, Mok-Won, et al.
Publicado: (2021)

Multivariate explanatory model for sporadic carcinoma of the colon in Dukes' stages I and IIa
por: Villadiego-Sánchez, J.M., et al.
Publicado: (2009)

Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
por: Liu, Qi, et al.
Publicado: (2019)

Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma
por: Lin, Chun-Yu, et al.
Publicado: (2017)

Comparison of survival outcomes between radical hysterectomy and definitive radiochemotherapy in stage IB1 and IIA1 cervical cancer
por: Wu, San-Gang, et al.
Publicado: (2017)

Survival comparison of stage IIA rectal cancer with or without neoadjuvant therapy: a SEER database analysis with propensity score matching
por: Yan, Han, et al.
Publicado: (2022)

A clinical risk model for assessing the survival of patients with stage IA–IIA non-small cell lung cancer after surgery
por: Qian, Jia-Yi, et al.
Publicado: (2022)

Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non‐small cell lung cancer
por: Zhang, Pei, et al.
Publicado: (2020)

The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa–IVa lower thoracic oesophageal squamous cell carcinoma
por: Wang, Yichun, et al.
Publicado: (2018)

Clinical Outcomes after Upfront Surgery in Clinical Stage I–IIA Small Cell Lung Cancer
por: Woo, Hyeok Sang, et al.
Publicado: (2022)

Radiotherapy for stage IIA rectal cancer may not benefit all
por: Hu, Xiang, et al.
Publicado: (2017)

Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry
por: Jones, David A., et al.
Publicado: (2022)

Combination of Estrogen Receptor Alpha and Histological Type Helps to Predict Lymph Node Metastasis in Patients with Stage IA2 to IIA2 Cervical Cancer
por: Ke, Yumin, et al.
Publicado: (2022)

A Pooled Analysis of Three Randomized Phase I/IIa Clinical Trials Confirms Absence of a Clinically Relevant Effect on the QTc Interval by Umibecestat
por: Vormfelde, Stefan Viktor, et al.
Publicado: (2020)

Prognostic Value of Metastatic N1 Lymph Node Ratio and Angiolymphatic Invasion in Patients With Pathologic Stage IIA Non-Small Cell Lung Cancer
por: Wu, Ching-Feng, et al.
Publicado: (2014)

Factors influencing lung cancer screening completion following participation in shared decision-making: A retrospective study in a U.S. academic health system
por: Rennert, Lior, et al.
Publicado: (2020)

Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer
por: Chen, Po-Huang, et al.
Publicado: (2022)

Pretreatment C‐reactive protein/albumin ratio is associated with poor survival in patients with stage IB‐IIA cervical cancer
por: Zhang, Weiwei, et al.
Publicado: (2017)

Morphological Characteristics and Clinical Significance of Different Types of Tumor Vessels in Patients with Stages I-IIA of Squamous Cervical Cancer
por: Senchukova, Marina A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_27q1rfvmjdmo47a76cuutaism7